GMO Quarterly Letter

GMO

Research

15 Pages

GMO examines why emerging market value stocks remained unusually attractive even after an 18% rally in emerging equities during 2017. The paper also argues that elevated U.S. market valuations reflect investor comfort with high margins, low inflation, and stable growth rather than long term fundamentals.

Key Takeaways

Emerging Value Advantage: MSCI Emerging Markets rose over 18% in 1H 2017, yet GMO still increased exposure after forecasting 6.2% real returns for emerging value stocks.
Extreme Relative Opportunity: Emerging value’s “margin of superiority” reached its highest level since 1994, leading GMO to raise its maximum emerging allocation from 25% to 30%.
Behavioral Valuation Drivers: Jeremy Grantham argues stock market volatility has been roughly 18x greater than fundamentals justify, driven by investor reactions to margins, inflation, and GDP stability.

Join our newsletter to have all of this content + Exclusive Newsletter Bonus Content delivered to your inbox every week

Scroll to Top